| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 3, 2593-2606, Copyright © 1989 by The Federation of American Societies for Experimental Biology
REVIEWS |
MB Gardner and PA Luciw
Department of Medical Pathology, University of California, Davis 95616.
Animal models of AIDS are essential for understanding the pathogenesis of retrovirus-induced immune deficiency and encephalopathy and for development and testing of new therapies and vaccines. AIDS and related disorders are etiologically linked to members of the lentivirus subfamily of retroviruses; these lymphocytopathic lentiviruses are designated human immuno-deficiency virus type 1 (HIV-1) and human immuno-deficiency virus type 2 (HIV-2). The only animals susceptible to experimental HIV-1 infection are the chimpanzee, gibbon ape, and rabbit but AIDS-like disease has not yet been reported in these species. Macaques can be persistently infected with some strains of HIV-2 but no AIDS-like disease has resulted. It is not yet clear how suitable HIV- infected SCID-hu mice will be as a model for AIDS. Several subfamilies of naturally occurring cytopathic retroviruses cause immune suppression, including fatal immunodeficiency syndromes in chickens, mice, cats, and monkeys. Domestic cats suffer immunosuppression from both an onco-virus, feline leukemia virus, and a member of the lentivirus subfamily, feline immunodeficiency virus (FIV). Asian macaques are susceptible to fatal simian AIDS from a type D retrovirus, indigenous in macaques, and from a lentivirus, simian immunodeficiency virus (SIV), which is indigenous to healthy African monkeys. SIV is the animal lentivirus most closely related to HIV. Of these animal models, the lentivirus infections of cats (FIV) and macaques (SIV) appear to bear the closest similarity in their pathogenesis to HIV infection and AIDS. This review will summarize these various animal model systems for AIDS and illustrate their usefulness for antiviral therapy and vaccinology.
This article has been cited by other articles:
|
|
 |
|
  G. Brennan, M. D. Podell, R. Wack, S. Kraft, J. L. Troyer, H. Bielefeldt-Ohmann, and S. VandeWoude Neurologic Disease in Captive Lions (Panthera leo) with Low-Titer Lion Lentivirus Infection J. Clin. Microbiol., December 1, 2006; 44(12): 4345 - 4352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Brandin, R. Thorstensson, S. Bonhoeffer, and J. Albert Rapid Viral Decay in Simian Immunodeficiency Virus-Infected Macaques Receiving Quadruple Antiretroviral Therapy J. Virol., October 1, 2006; 80(19): 9861 - 9864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gorantla, K. Santos, V. Meyer, S. Dewhurst, W. J. Bowers, H. J. Federoff, H. E. Gendelman, and L. Poluektova Human Dendritic Cells Transduced with Herpes Simplex Virus Amplicons Encoding Human Immunodeficiency Virus Type 1 (HIV-1) gp120 Elicit Adaptive Immune Responses from Human Cells Engrafted into NOD/SCID Mice and Confer Partial Protection against HIV-1 Challenge J. Virol., February 15, 2005; 79(4): 2124 - 2132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Ryan, D. Klein, E. Knapp, M. J. Hosie, T. Grimes, M. J. E. M. F. Mabruk, O. Jarrett, and J. J. Callanan Dynamics of Viral and Proviral Loads of Feline Immunodeficiency Virus within the Feline Central Nervous System during the Acute Phase following Intravenous Infection J. Virol., July 1, 2003; 77(13): 7477 - 7485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. T. Keppler, F. J. Welte, T. A. Ngo, P. S. Chin, K. S. Patton, C.-L. Tsou, N. W. Abbey, M. E. Sharkey, R. M. Grant, Y. You, et al. Progress Toward a Human CD4/CCR5 Transgenic Rat Model for De Novo Infection by Human Immunodeficiency Virus Type 1 J. Exp. Med., March 18, 2002; 195(6): 719 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Holterman, R. Dubbes, J. Mullins, G. Learn, H. Niphuis, W. Koornstra, G. Koopman, E.-M. Kuhn, A. Wade-Evans, B. Rosenwirth, et al. Characteristics of a Pathogenic Molecular Clone of an End-Stage Serum-Derived Variant of Simian Immunodeficiency Virus (SIVF359) J. Virol., October 1, 2001; 75(19): 9328 - 9338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-H. Chow, P. Li, G. Brookshier, and Y. Tang In Vivo Tissue Disposition of 3'-Azido-3'-deoxythymidine and Its Anabolites in Control and Retrovirus-Infected Mice Drug Metab. Dispos., April 1, 1997; 25(4): 412 - 422. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Barnett, K. Murthy, B. Herndier, and J. Levy An AIDS-like condition induced in baboons by HIV-2 Science, October 28, 1994; 266(5185): 642 - 646. [Abstract] [PDF]
|
|
|
|
|
|
M. Agy, L. Frumkin, L Corey, R. Coombs, S. Wolinsky, J Koehler, W. Morton, and M. Katze Infection of Macaca nemestrina by human immunodeficiency virus type-1 Science, July 3, 1992; 257(5066): 103 - 106. [Abstract] [PDF]
|
|
|
|
|
|
H Mitsuya, R Yarchoan, and S Broder Molecular targets for AIDS therapy Science, September 28, 1990; 249(4976): 1533 - 1544. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Mummidi, M. Bamshad, S. S. Ahuja, E. Gonzalez, P. M. Feuillet, K. Begum, M. C. Galvis, V. Kostecki, A. J. Valente, K. K. Murthy, et al. Evolution of Human and Non-human Primate CC Chemokine Receptor 5 Gene and mRNA. POTENTIAL ROLES FOR HAPLOTYPE AND mRNA DIVERSITY, DIFFERENTIAL HAPLOTYPE-SPECIFIC TRANSCRIPTIONAL ACTIVITY, AND ALTERED TRANSCRIPTION FACTOR BINDING TO POLYMORPHIC NUCLEOTIDES IN THE PATHOGENESIS OF HIV-1 AND SIMIAN IMMUNODEFICIENCY VIRUS J. Biol. Chem., June 16, 2000; 275(25): 18946 - 18961. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
